Correlation Between Cognition Therapeutics and Axsome Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Axsome Therapeutics, you can compare the effects of market volatilities on Cognition Therapeutics and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Axsome Therapeutics.
Diversification Opportunities for Cognition Therapeutics and Axsome Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cognition and Axsome is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Axsome Therapeutics go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Axsome Therapeutics
Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Axsome Therapeutics. In addition to that, Cognition Therapeutics is 2.22 times more volatile than Axsome Therapeutics. It trades about -0.24 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.18 per unit of volatility. If you would invest 9,035 in Axsome Therapeutics on August 30, 2024 and sell it today you would earn a total of 930.00 from holding Axsome Therapeutics or generate 10.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognition Therapeutics vs. Axsome Therapeutics
Performance |
| Timeline |
| Cognition Therapeutics |
| Axsome Therapeutics |
Cognition Therapeutics and Axsome Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Axsome Therapeutics
The main advantage of trading using opposite Cognition Therapeutics and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.| Cognition Therapeutics vs. Bright Minds Biosciences | Cognition Therapeutics vs. HP Inc | Cognition Therapeutics vs. Intel | Cognition Therapeutics vs. Chevron Corp |
| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |